1. Prevention and early detection of prostate cancer
Prof Jack Cuzick, PhD, Mangesh A Thorat, MBBS, Prof Gerald Andriole, MD, Prof Otis W Brawley, MD, Prof Powel H Brown, MD, Zoran Culig, MD, Prof Rosalind A Eeles, PhD, Leslie G Ford, MD, Prof Freddie C Hamdy, MD, Prof Lars Holmberg, MD, Dragan Ilic, PhD, Prof Timothy J Key, DPhil, Prof Carlo La Vecchia, MD, Prof Hans Lilja, MD, Prof Michael Marberger, MD, Prof Frank L Meyskens, MD, Lori M Minasian, MD, Chris Parker, MD, Howard L Parnes, MD, Prof Sven Perner, MD, Harry Rittenhouse, PhD, Prof Jack Schalken, PhD, Prof Hans-Peter Schmid, MD, Prof Bernd J Schmitz-Dräger, MD, Prof Fritz H Schröder, MD, Prof Arnulf Stenzl, MD, Prof Bertrand Tombal, MD, Prof Timothy J Wilt, MD, Prof Alicja Wolk, DrMedSci 
The Lancet Oncology 
Volume 15, Issue 11, Pages e484-e492 (October 2014)
DOI: /S (14)
Copyright © 2014 Elsevier Ltd Terms and Conditions

2. Figure 1 Prevention and early detection of prostate cancer
Modifiable and non-modifiable risk factors, pharmacological agents, and triage strategies for prevention and early detection of prostate cancer, many of which are yet to be established. IHC=immunohistochemistry. FISH=fluorescent in-situ hybridisation. SNP=single-nucleotide polymorphism.
The Lancet Oncology  , e484-e492DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions